Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Calcium blockers

Verapamil (Table 1), the first slow channel calcium blocker synthesized to selectively inhibit the transmembrane influx of calcium ions into cells, lowers blood pressure in hypertensive patients having good organ perfusion particularly with increased renal blood flow. Sustained-release verapamil for once a day dosing is available for the treatment of hypertension. Constipation is a prominent side effect. Headache, dizziness, and edema are frequent and verapamil can sometimes cause AV conduction disturbances and AV block. Verapamil should not be used in combination with -adrenoceptor blockers because of the synergistic negative effects on heart rate and contractile force. [Pg.142]

Despite the growth in interest in calcium blockers, there are comparatively few calcium channel blocking agents currently in clinical use. These drugs are characterised by the fact that they belong to classes of compounds which are chemically unrelated like Diltiazem , Nifedipine , Verapamil , Fluspirilene and some others (Scheme 1). [Pg.152]

One source of calcium ions, which cause contraction of smooth muscle in arterial walls, is inflow through ion-specific channels. So, the calcium blockers block the channels, limiting inflow of calcium and keeping muscle cells in relaxed states for a longer time. [Pg.153]

Napoli et al. [286] found that the nifedipine treatment of stroke-prone spontaneously hypertensive rats (SPSHR) suppressed the plasma and LDL oxidation and the formation of oxidation-specific epitopes and increased the survival of rats independently of blood pressure modification. Their results suggest that the protective effects of calcium blockers of dihydro-pyridine-type on cerebral ischemia and stroke may, at least in part, depend on their antioxidant activity. In vivo antioxidant effect of nilvadipine on LDL oxidation has been studied in hypertensive patients with high risk of atherosclerosis [287], It was found that there was a significant decrease in the level of LDL cholesterol oxidation in patients after nilvadipine treatment. [Pg.884]

Calcium antagonists are able to affect nitric oxide production and suppress the peroxyni-trite-induced damage. Thus, nifedipine enhanced the bioavailability of endothelial NO in porcine endothelial cell cultures supposedly through an antioxidative mechanism [288], Pretreatment with nisoldipine, a vascular-selective calcium blocker of dihydropyridine-type, of confluent bovine aortic endothelial cells suppressed the peroxynitrite-induced GSH loss and increased cell survival [289]. [Pg.884]

Similar to dihydropyridine calcium blockers, many 0-adrenoreceptor antagonists exhibit antioxidant activity. Mak and Weglinski [290] showed that the pretreatment of canine myocytic sarcolemmal membranes with 0-adrenoreceptor antagonists (propranolol, pindolol, metoprolol, atenolol, or sotalol) (Figure 29.15) inhibited superoxide-induced sarcolemmal... [Pg.884]

Amlodipine (Norvasc) Calcium-blocker Amoxapine (Asendin) Antidepressant Amoxicillin (Amoxil) Antibiotic... [Pg.5]

Isotretinoin (Accutane) Anti-acne Isradipine (DynaCirc, Calcium-blocker DynaCirc CR)... [Pg.33]

Propranolol has been studied most carefully in experiments and in clinics. It is used for ventricular tachycardia, arrhythmia caused by digitalis drug overdose, or as a result of thy-rotoxosis or excess catecholamine activity. Despite the fact that there are a number of )8-adrenoblockers, propranolol is considered the first choice of drugs although other blockers of calcium blockers can be just as effective. [Pg.252]

Drugs that may affect calcium blockers include amiodarone, antineoplastics, azole... [Pg.491]

Drugs that may affect beta blockers include aluminum salts, barbiturates, calcium salts, cholestyramine, cimetidine, colestipol, diphenhydramine, hydroxychloroquine, NSAIDs, penicillins (ampicillin), rifampin, salicylates, SSRIs, sulfinpyrazole, calcium blockers, oral contraceptives, flecainide, haloperidol, hydralazine, loop diuretics,... [Pg.527]

Drugs that may be affected by carvedilol include antidiabetic agents, calcium blockers, clonidine, cyclosporine, disopyramide, catecholamine depleting agents (eg, reserpine), and digoxin. [Pg.537]

Diuretics or beta blockers-- 2. ACE inhibitors, calcium blockers, alpha-] blockers, alpha-beta blocker ... [Pg.545]

Drugs that may be affected by itraconazole include alfentanil, almotriptan, alprazolam, amphotericin B, aripiprazole, benzodiazepines, buspirone, busulfan, calcium blockers, carbamazepine, cilostazol, cisapride, corticosteroids, cyclosporine, digoxin, disopyramide, docetaxel, dofetilide, eletriptan, epierenone, ergot alkaloids, haloperidol, HMG-CoA reductase inhibitors, hydantoins (phenytoin), hypoglycemic agents, oral midazolam, phosphodiesterase type 5 inhibitors, pimozide, polyenes, protease inhibitors, quinidine, rifamycins, sirolimus, tacrolimus, tolterodine, triazolam, trimetrexate, vinca alkaloids, warfarin, and zolpidem. [Pg.1688]

Verapamil has been shown to block the P-glycoprotein responsible for the transport of many foreign drugs out of cancer (and other) cells (see Chapter 1) other calcium channel blockers appear to have a similar effect. This action is not stereospecific. Verapamil has been shown to partially reverse the resistance of cancer cells to many chemotherapeutic drugs in vitro. Some clinical results suggest similar effects in patients (see Chapter 54). Animal research suggests possible future roles of calcium blockers in the treatment of osteoporosis, fertility disorders and male contraception, immune modulation, and even schistosomiasis. [Pg.262]

While they are often prescribed, the lower costs of codeine, ACE inhibitors, beta-blockers, thyroid hormones, calcium blockers, and benzodiazepines keep them off the list of top sales. Conversely, the higher cost of erythropoietins, antineo monoclonal antibodies, angiotensin II antagonists, antiarthritis drugs, and bisphosphonates put them on the list of top sales but not top prescriptions. [Pg.21]

Smidt and Langner111"1 in their synthesis of the natural calcium blocker leualacin utilized the Mitsunobu reaction for the construction of the linear depsipeptide N-(tert-but oxycarbony I) -(3-alanyl-O-D-leucic acid benzyl ester in 69% yield. Higher yields (94-96%) were reported for two didepsipeptide units N-(/er/-butoxycarbonyl)-./V-methylleucyl-D-lactic acid diphen-ylmethyl ester and iV-(/er/-butoxycarbonyl)-yV-methylleucyl-D-phenyllactic acid diphe-nylmethyl ester in the course of the total synthesis of the anthelmintic cyclooctadepsipeptide PF1022A based on the Mitsunobu reaction.1102 ... [Pg.283]

Hollt, V., M. Kouba, M. Dietel, and G. Vogt. 1992. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Biochem Pharmacol 43 2601. [Pg.109]

Ethanol is a vasodilator, probably as a result of both central nervous system effects (depression of the vasomotor center) and direct smooth muscle relaxation caused by its metabolite, acetaldehyde. In cases of severe overdose, hypothermia—caused by vasodilation—may be marked in cold environments. Ethanol also relaxes the uterus and—before the introduction of more effective and safer uterine relaxants (eg, calcium blockers, magnesium ion, NSAIDs, and -adrenoceptor stimulants)—was used intravenously for the suppression of premature labor. [Pg.535]


See other pages where Calcium blockers is mentioned: [Pg.257]    [Pg.153]    [Pg.153]    [Pg.262]    [Pg.883]    [Pg.883]    [Pg.883]    [Pg.885]    [Pg.42]    [Pg.491]    [Pg.546]    [Pg.395]    [Pg.214]    [Pg.284]    [Pg.329]    [Pg.238]    [Pg.251]    [Pg.685]    [Pg.20]    [Pg.884]    [Pg.884]    [Pg.884]    [Pg.886]    [Pg.170]    [Pg.257]    [Pg.305]    [Pg.250]    [Pg.498]    [Pg.39]   
See also in sourсe #XX -- [ Pg.222 ]




SEARCH



Acute coronary syndromes calcium channel blockers

Adverse reactions calcium-channel blockers

Amiodarone Calcium-channel blockers

Anaesthetics, general Calcium-channel blockers

Anaesthetics, general Calcium-channel blockers, dihydropyridine (

Anaesthetics, local Calcium-channel blockers

Angina pectoris calcium channel blockers

Antianginal drugs calcium channel blockers

Antiarrhythmic drugs calcium channel blocker

Anticoagulants calcium channel blockers

Antihypertensive drugs calcium channel blockers

Antihypertensives calcium channel blockers

Antiplatelet agents calcium channel blockers

Astemizole Calcium-channel blockers

Asthma, calcium channel blockers

Atorvastatin Calcium-channel blockers

Atrial fibrillation calcium channel blockers

Azoles Calcium-channel blockers

Benzodiazepines calcium channel blockers

Benzothiazepine calcium channel blockers

Bipolar disorder calcium channel blockers

Bupivacaine Calcium-channel blockers

Buspirone calcium channel blockers

Calcium antagonists blockers

Calcium channel agonists blockers

Calcium channel blocker angina treatment

Calcium channel blocker cardiac effects

Calcium channel blocker dihydropyridines

Calcium channel blocker drugs

Calcium channel blocker hypertension treatment

Calcium channel blockers

Calcium channel blockers (CCBs

Calcium channel blockers (CCBs hypertension

Calcium channel blockers , and

Calcium channel blockers 1-4 dihydropyridine derivatives

Calcium channel blockers adverse effects

Calcium channel blockers agents

Calcium channel blockers analgesics

Calcium channel blockers angina

Calcium channel blockers antagonists

Calcium channel blockers antianginal

Calcium channel blockers antianginals

Calcium channel blockers antiarrhythmics

Calcium channel blockers arrhythmias (class

Calcium channel blockers binding

Calcium channel blockers binding sites

Calcium channel blockers cardiac glycosides

Calcium channel blockers categories

Calcium channel blockers causative agents

Calcium channel blockers cell culture

Calcium channel blockers classes

Calcium channel blockers classification

Calcium channel blockers clinical presentation

Calcium channel blockers constipation with

Calcium channel blockers contraindications

Calcium channel blockers definition

Calcium channel blockers development

Calcium channel blockers diseases

Calcium channel blockers dosage

Calcium channel blockers dosing

Calcium channel blockers drug interactions with

Calcium channel blockers effects

Calcium channel blockers for hypertension

Calcium channel blockers gastrointestinal effects

Calcium channel blockers heart failure with

Calcium channel blockers hypertensive renal disease

Calcium channel blockers in acute coronary syndromes

Calcium channel blockers in arrhythmias

Calcium channel blockers in bipolar disorder

Calcium channel blockers in hypertension

Calcium channel blockers in ischemic heart disease

Calcium channel blockers incidence

Calcium channel blockers indications

Calcium channel blockers lithium

Calcium channel blockers management

Calcium channel blockers mechanism of action

Calcium channel blockers metabolism

Calcium channel blockers migraine prophylaxis

Calcium channel blockers monitoring

Calcium channel blockers negative chronotropic effects

Calcium channel blockers negative inotropic effects

Calcium channel blockers pharmacokinetics

Calcium channel blockers pharmacological effects

Calcium channel blockers phenylalkylamine

Calcium channel blockers phenylalkylamines

Calcium channel blockers poisoning with

Calcium channel blockers preparations

Calcium channel blockers prevention

Calcium channel blockers properties

Calcium channel blockers selectivity

Calcium channel blockers side effects

Calcium channel blockers specific agents

Calcium channel blockers supply

Calcium channel blockers tacrolimus nephrotox

Calcium channel blockers tardive dyskinesia

Calcium channel blockers theophylline

Calcium channel blockers treatment with concomitant

Calcium channel blockers types

Calcium channel blockers, specific

Calcium ion channel blocker

Calcium-channel blockers ACE inhibitors

Calcium-channel blockers Alcohol

Calcium-channel blockers actions

Calcium-channel blockers dihydropyridine

Calcium-channel blockers interactions

Calcium-entry blockers

Carbamazepine Calcium-channel blockers

Cardiac circulatory medications calcium channel blockers

Cardiac drugs calcium channel blockers

Cardiomyopathy calcium channel blockers

Cardiovascular agents calcium channel blockers

Cephalosporins Calcium-channel blockers

Ciclosporin Calcium-channel blockers

Cimetidine Calcium-channel blockers

Clonidine Calcium-channel blockers

Clopidogrel Calcium-channel blockers

Dantrolene Calcium-channel blockers

Diazepam Calcium-channel blockers

Dihydropyridine calcium-channel blockers Dihydropyridines)

Doxorubicin Calcium-channel blockers

Drug interactions calcium-channel blockers

Fluconazole Calcium-channel blockers

Fluoxetine Calcium-channel blockers

Foods Calcium-channel blockers

Gingival hyperplasia calcium channel blockers

Headache calcium-channel blockers

Heart failure calcium channel blockers

Heart failure, chronic calcium channel blockers

Hydrochlorothiazide Calcium-channel blockers

Hypertension calcium channel blockers

IV Calcium Channel Blockers

Imatinib Calcium-channel blockers

Insulin Calcium-channel blockers

Ischemic heart disease calcium channel blockers

Itraconazole Calcium-channel blockers

Ketoconazole Calcium-channel blockers

Lovastatin Calcium-channel blockers

Macrolides Calcium-channel blockers

Mefloquine Calcium-channel blockers

Midazolam Calcium-channel blockers

Migraine calcium channel blockers

Myocardial infarction calcium channel blockers

Myocardial infarction calcium channel blockers adversely

N-Type Calcium Channel Blockers

Naproxen Calcium-channel blockers

Nimodipine Calcium-channel blockers

Nitrates Calcium-channel blockers

Nondihydropyridine calcium-channel blockers

Phenobarbital Calcium-channel blockers

Phenothiazines Calcium-channel blockers

Phenytoin Calcium-channel blockers

Prescription drugs calcium channel blockers

Protease inhibitors Calcium-channel blockers

Proteinuria calcium channel blockers

Quinidine Calcium-channel blockers

Quinupristin/Dalfopristin Calcium-channel blockers

Ranitidine Calcium-channel blockers

Rifabutin Calcium-channel blockers

Rifampicin Calcium-channel blockers

Sertindole Calcium-channel blockers

Sildenafil Calcium-channel blockers

Simvastatin Calcium-channel blockers

Sinoatrial node, calcium channel blocker

Sirolimus Calcium-channel blockers

Statins Calcium-channel blockers

Structure-activity relationships calcium channel blockers

T-Type Calcium Channel Blockers

Tacrolimus Calcium-channel blockers

Terfenadine Calcium-channel blockers

Theophylline, consider Calcium-channel blockers

Vasodilators calcium channel blockers

Warfarin Calcium-channel blockers

© 2024 chempedia.info